Virtual Medicinal Product (VMP)
-
Mebendazole 100mg/5ml oral suspension
Name Details
Current Name
Mebendazole 100mg/5ml oral suspension
|
Start Date
10-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
P02CA01
BNF |
Current BNF
05050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05050100
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41791611000001101 |
12-05-2023 |
|
324962006 |
10-11-2002 |
11-05-2023 |
VMP Ingredients
VMP ingredients table
Mebendazole |
Based on Ingredient Substance |
|
20 mg |
1 ml |
Name
Mebendazole
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Mebendazole
-
VMP
(Current) Mebendazole 100mg/5ml oral suspension
Virtual Medicinal Product Pack (VMPP) Information
30 ml |
155 |
Part VIIIA Category C |